Active ingredient
Iomeprol
16 finished FDA listings contain Iomeprol as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- IOMEPROL
- Dosage forms
- Injection, Solution
- Routes
- Intra-Arterial, Intravascular, Intravenous
- Manufacturers / labelers
- 2
- Strengths listed
- 510 mg/ml · 612 mg/ml · 714 mg/ml · 816 mg/ml
- Brand names in FDA listings
- Iomeron, Iomervu
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2606484
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 216016 | BRACCO | 2024-11-27 | 2 |
Official labeling on DailyMed
- IOMERVU (IOMEPROL INJECTION) INJECTION, SOLUTION [BRACCO DIAGNOSTICS INC] · version 4 · 2026-02-09
- IOMERON (IOMEPROL INJECTION) INJECTION, SOLUTION [BIPSO GMBH] · version 5 · 2025-11-21
- IOMERON (IOMEPROL INJECTION) INJECTION, SOLUTION [BRACCO DIAGNOSTICS INC] · version 5 · 2025-11-21
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.